2022
DOI: 10.1016/j.jpcs.2021.110322
|View full text |Cite
|
Sign up to set email alerts
|

Design and synthesis of nickel tetra‐2,3‐pyridiniumporphyrazinato trinitromethanide as an influential catalyst and its application in the synthesis of 1,2,4-triazolo based compounds

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

3
2

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 38 publications
0
4
0
Order By: Relevance
“…To continue our investigations in this field [65][66][67][68][69][70] , herein, we synthesized numerous pyrimidine-6-carbonitrile, pyrimidin-5-one, and tetrahydroquinoline-3-carbonitrile compounds via a cooperative geminal-vinylogous anomeric based oxidation under solvent-free conditions at 100 °C (Fig. 2) by using oxovanadium(V)-[5,10,15,20tetrakis(pyridinium)-porphyrinato]-tetra(tricyanomethanide) [(VO)TPP][(TCM) 4 ] as a versatile catalyst (Fig.…”
Section: Synthesismentioning
confidence: 96%
“…To continue our investigations in this field [65][66][67][68][69][70] , herein, we synthesized numerous pyrimidine-6-carbonitrile, pyrimidin-5-one, and tetrahydroquinoline-3-carbonitrile compounds via a cooperative geminal-vinylogous anomeric based oxidation under solvent-free conditions at 100 °C (Fig. 2) by using oxovanadium(V)-[5,10,15,20tetrakis(pyridinium)-porphyrinato]-tetra(tricyanomethanide) [(VO)TPP][(TCM) 4 ] as a versatile catalyst (Fig.…”
Section: Synthesismentioning
confidence: 96%
“…There are publications describing the use of various other green catalysts for the synthesis of triazoloqiunolinones: e. g., nickel tetra-2,3-pyridiniumporphyrazinato trinitromethanide, [131] p-toluenesulfonic acid monohydrate, [132] anthranilic acid, [133,134] trimethyl amine N-oxide [135] and other.…”
Section: Reactions Of Aminotriazolesmentioning
confidence: 99%
“…They can be used as cognitive enhancers for the treatment of neurodegenerative diseases, including Alzheimer's disease, amyotrophic lateral sclerosis, Huntington's disease, Parkinson's disease, AIDS associated dementia, and Down's syndrome, as well as for the treatment of schizophrenia and myoclonus. [24][25][26][27][28] Building upon our earlier investigations, [29][30][31][32][33][34][35][36] this study introduces a new catalyst for the synthesis of polyhydroquinoline and chromene derivatives, specifically the vanadiumoxotetrapyridinoporphyrazine zwitterionic catalyst [VO-(TPPACH 2 CO 2 H)]Cl, which has been modified with acetic acid (Figure 1). This catalyst exhibits dual functionality, possessing both Lewis and Brønsted acid properties within its molecular structure.…”
Section: Introductionmentioning
confidence: 99%
“…Building upon our earlier investigations, [29–36] this study introduces a new catalyst for the synthesis of polyhydroquinoline and chromene derivatives, specifically the vanadium‐oxotetrapyridinoporphyrazine zwitterionic catalyst [VO(TPPACH 2 CO 2 H)]Cl, which has been modified with acetic acid (Figure 1). This catalyst exhibits dual functionality, possessing both Lewis and Brønsted acid properties within its molecular structure.…”
Section: Introductionmentioning
confidence: 99%